Comparison of short term bleeding-related health care utilization and costs among treatment-naïve non-valvular atrial fibrillation patients initiating apixaban, dabigatran, rivoxaban or warfarin
Citation
Keshishian A, Xie L Baser O, Price K, Vo L, Singh P, Bruno A, Mardekian J, Tan W, Singha S, Patel C, Odell K, Trocio J. (24-28 October 2015). Comparison of short term bleeding-related health care utilization and costs among treatment-naïve non-valvular atrial fibrillation patients initiating apixaban, dabigatran, rivoxaban or warfarin. American College of Chest Physicians CHEST Annual Meeting 2015. Montreal, QC, Canada.Abstract
...
